March 8, 2023 – FDA advisers question the efficacy of Roche’s Polivy in first-line LBCL














March 8, 2023: FDA advisers query the efficacy of Roche’s Polivy in front-line LBCL | cafefarma




#March #FDA #advisers #query #efficacy #Roches #Polivy #firstline #LBCL

Leave a Reply

Your email address will not be published. Required fields are marked *